Discover Personalized Insights for Medication Response

Precision Primary

With Precision Primary, unlock a gateway to personalized medication management.

PRECISION PRIMARY

Our Comprehensive Health Solution

With Precision Primary, discover personalized insights for medication response. Our solution provides decision support used to identify genetic variants affecting drug metabolism and information about how patients respond to commonly prescribed medications. With this simple genetic test, providers can identify safer and more effective medications for patients.

Personalized medication prescribing

Genetics impact how our bodies respond to medications.¹ With our comprehensive health solution, providers now have a decision support tool help guide the right medication, for the right patient, at the right time. Precision Primary leverages a robust pharmacogenetic database of gene-drug interactions to evaluate commonly prescribed drugs including pain medications (e.g., opioids, NSAIDs), cardiovascular medications (e.g., statins, anticoagulants, antiplatelets), psychotropic medications (e.g., antidepressants, antipsychotics), and many others.

Why Choose Precision Primary

By analyzing specific genes involved in drug metabolism, our results provide vital information about how patients are likely to respond to various medications. This enables providers to tailor treatment plans based on their unique genetic profiles, maximizing efficacy while minimizing adverse reactions. Precision Primary has been clinically validated and adheres to the latest CPIC guidelines. With our solution, providers can have access to:

Expansive drug catalog with over 70 therapeutic categories
Analyzes 60 genetic polymorphisms in 14 genes
Customizable drug class reporting, relevant to your patient or practice

Who Benefits?

Don’t settle for one-size-fits-all healthcare. Embrace the future of medicine with our comprehensive testing solution. Testing can benefit a wide range of patients, including those:

Did You Know?

Of patients have actionable results

0 %

Roughly 30% of the U.S. population have actionable results for certain drug-gene pairs as defined by CPIC for common medications¹

Per patient reduction

$ 0

Roughly $7k/per patient reduction in direct medical costs for patients 65 years and older with polypharmacy²

Of patients have genetic risks

0 %

One study cited “100% of participants had at least one variant known to impact medication therapy outcome and 66% of participants had genetic risks detected in a currently prescribed medication”²

Who Benefits?

Don’t settle for one-size-fits-all healthcare. Embrace the future of prescribing with our comprehensive testing solution. Testing can benefit a wide range of patients, including those:

Treatment Resistant

Patients who have experienced inadequate response or adverse reactions to medications despite adherence to treatment regimens.

Complex Medical Histories

Patients with complex medical histories, comorbidities, or chronic conditions requiring long-term medication management.

Multiple Medications

Individuals taking multiple medications concurrently, increasing the risk of drug-drug interactions and adverse reactions.

Considering New Medications

Individuals initiating new medications for which pharmacogenetics testing can inform safer and more effective treatment options.

Sample Report

Providers can create customizable reports, specific to their practice preferences, leading to better outcomes. Patients can have the confidence in knowing that their treatment plan is uniquely their own.

Unlock the insights hidden in your genes.

[1] Luzum JA, Pakyz RE, Elsey AR, et al. The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare Systems. Clin Pharmacol Ther. 2017;102(3):502-510. doi:10.1002/cpt.630
[2] Jarvis JP, Peter AP, Keogh M, et al. Real-World Impact of a Pharmacogenomics-Enriched Comprehensive Medication Management Program. J Pers Med. 2022;12(3). doi:10.3390/jpm12030421